.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201370

« Back to Dashboard
NDA 201370 describes HEPARIN SODIUM PRESERVATIVE FREE, which is a drug marketed by Sagent Pharms, Hospira, Fresenius Kabi Usa, Pharma Serve Ny, Shenzhen Techdow, Watson Labs Inc, and Pfizer, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the HEPARIN SODIUM PRESERVATIVE FREE profile page.

The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for NDA: 201370

Tradename:
HEPARIN SODIUM
Applicant:
Pfizer
Ingredient:
heparin sodium
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 201370

Ingredient-typeHeparin

Suppliers and Packaging for NDA: 201370

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION 201370 NDA Pfizer Laboratories Div Pfizer Inc 0069-0043 0069-0043-01 25 VIAL in 1 CONTAINER (0069-0043-01) > 2 mL in 1 VIAL (0069-0043-02)
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION 201370 NDA Pfizer Laboratories Div Pfizer Inc 0069-0043 0069-0043-02 2 mL in 1 VIAL (0069-0043-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1,000 UNITS/ML
Approval Date:Jul 21, 2011TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/ML
Approval Date:Jul 21, 2011TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/ML
Approval Date:Jul 21, 2011TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc